Acknowledgements
Download 143.1 Kb.
|
BIBLIOGRAPHY Årdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. The Lancet. 2016;387(10015):296-307. Armstrong, GL, Conn LA and RW Pinner. Trends in infectious disease mortality in the United States during the 20th century. JAMA. 1999;281(1): 61-66. Bai AD, Showler A, Burry L, Steinberg M, Ricciuto DR, Fernandes T, et al. Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study. Clin Infect Dis. 2015;60(10):1451-61. Brown K, Valenta K, Fisman D, Simor A, and N Daneman. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med. 2015;175(4):626-33. Burke, JP. Antibiotic Resistance—Squeezing the Balloon? JAMA. 1998;280(14): 1270-1271. Canada A. Required Organizational Practices Handbook 2017. Ottawa, Canada: Accreditation Canada; 2016. Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, Pepin J. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol. 2012;62(3):453-9. CDC. Core elements of hospital antibiotic stewardship programs. In: Services UDoHaH, editor. Atlanta, GA: The National Center for Emerging and Zoonotic Infectious Diseases; 2014. Charani E, Castro-Sanchez E, Sevdalis N et al. Understanding the determinants of antimicrobial prescribing within hospitals: The role of “prescribing etiquette. Clinical Infectious Diseases 2013;57(2):188–96. Chastre, J, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290(19): 2588-2598. Chen DK, McGeer A, de Azavedo JC, and DE Low. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med. 1999;341(4):233-9. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, and Y Carmeli. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26(2):166-74. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-77. Demczuk W, Martin I, Peterson S, Bharat A, Van Domselaar G, Graham M, et al. Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014. J Clin Microbiol. 2016;54(5):1304-13. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2013. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2014. Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, and ML Schweizer. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(7):1748-54. Fleming A, Chain E, et al. Penicillin and streptomycin. Lancet. 1947;2(6472):397. Freedberg DE, Salmasian H, Cohen B, Abrams JA, and EL Larson. Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed. JAMA Intern Med. 2016. Haley RW, Morgan WM, Culver DH, White JW, Emori TG, Mosser J, et al. Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment. Am J Infect Control. 1985;13(3):97-108. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nature genetics. 2013;45(1):109-13. Hecker MT, Aron DC, Patel NP, Lehmann MK and CJ Donskey. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003;163(8): 972-978. Hooton TM et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med. 2000;343(14): 992-997. Hughes JM. Study on the efficacy of nosocomial infection control (SENIC Project): results and implications for the future. Chemotherapy. 1988;34(6):553-61. Kim JH, and HA Gallis. Observations on Spiraling Empiricism: Its Causes, Allure, and Perils with Particular Reference to Antibiotic Therapy. Am J Med. 1989;87:201-206. Le Coz, P, Carlet, J, Roblot F, and C Pulcini. Ressources humaines nécessaires aux équipes multidisciplinaires en antibiothérapie dans les établissements de santé français. Medecine et Maladies Infectieuses 2016; 46(4): 200-206. Leal JR, Heitman SJ, Conly JM, Henderson EA, and BJManns. Cost-Effectiveness Analysis of the Use of Probiotics for the Prevention of Clostridium difficile-Associated Diarrhea in a Provincial Healthcare System. Infect Control Hosp Epidemiol. 2016;37(9):1079-86. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825-34. Li C, Wang H, Yin M, Han H, Yue JF, Zhang F, et al. The Differences in the Epidemiology and Predictors of Death between Candidemia Acquired in Intensive Care Units and Other Hospital Settings. Intern Med. 2015;54(23):3009-16. Lin, L, K Fajardo and U. S. P. S. T. Force. Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008;149(1): W20-24. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442-9. Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010). Intensive Care Med. 2014;40(9):1303-12. MacDougall, CJ, Powell P, Johnson CL, Edmond MB and RE Polk. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis. 2005;41(4): 435-440. Maslikowska JA, Walker SA, Elligsen M, Mittmann N, Palmay L, Daneman N, et al. Impact of infection with extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. J Hosp Infect. 2016;92(1):33-41. McGowan JE, Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis. 1983;5(6):1033-48. Meyer, E, Gastmeier E, Deja M and F Schwab. Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol. 2013;303(6-7): 388-395. Miller MA, Hyland M, Ofner-Agostini M, Gourdeau, M, and M Ishak. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infection Control & Hospital Epidemiology. 2002;23(03), 137-140. Mitchell BG, Gardner A. Mortality and Clostridium difficile infection: a review. Antimicrobial resistance and infection control. 2012;1(1):20. Novotny J, and M Novotny. Adverse drug reactions to antibiotics and major antibiotic drug interactions. Gen. Physiol. Biophys. 1999;18:126–139. O'Boyle C, Jackson M, and SJ Henly. Staffing requirements for infection control programs in US health care facilities: Delphi project. Am J Infect Control. 2002;30(6):321-33. Owens RC, Jr., Donskey CJ, Gaynes RP, Loo VG, and CA Muto. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S19-31. Patrick K. Antibiotic stewardship and pharma's social conscience. CMAJ. 2016;188(7):483. Public Health Agency of Canada. Canadian Antimicrobial Resistance Surveillance System--Report 2016. Ottawa, Canada; 2016. Public Health Agency of Canada. Essential Resources for Effective Infection Prevention and Control Programs: A Matter of Patient Safety - A Discussion Paper. In: Control CfCDaI, editor. Ottawa, ON: Health Canada; 2010. Rafailidis, PI, AI Pitsounis and ME Falagas. Meta-analyses on the optimization of the duration of antimicrobial treatment for various infections. Infect Dis Clin North Am. 2009;23(2): 269-276 Rahal, JJ, et al. Class Restriction of Cephalosporin Use to Control Total Cephalosporin Resistance in Nosocomial Klebsiella. JAMA. 1998;280(14): 1233-123. Rajendran R, Sherry L, Deshpande A, Johnson EM, Hanson MF, Williams C, et al. A Prospective Surveillance Study of Candidaemia: Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients. Front Microbiol. 2016;7:915. Rice, LB. The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and Clostridium difficile. Clin Infect Dis. 2008;6(4): 491-496. Rushton CH. Creating a Culture of Ethical Practice in Health Care Delivery Systems. The Hastings Center report. 2016;46 Suppl 1:S28-31. Sandberg, T et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet. 2012; 380(9840): 484-490. Santé et Services sociaux Québec. Comité d'examen sur la prévention et le contrôle des infections nosocomiales. D'abord ne pas nuire... les infections nosocomiales au Québec, un problème majeur de santé, une priorité. Québec City, QC2002. Sawyer, RG et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med. 2015; 372(21): 1996-2005. Schuts EC, Hulscher ME, Mouton JW, Verduin CM, Stuart JW, Overdiek HW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847-56. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997;337(7):441-6. Shore CK, Coukell A. Roadmap for antibiotic discovery. Nat Microbiol. 2016;1(6):16083. Sievert, Dawn M, et al. Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infection Control; Hospital Epidemiology. 2013;34(1). Silver SA, Baillie L and AE Simor. Positive urine cultures: A major cause of inappropriate antimicrobial use in hospitals? Can J Infect Dis Med Microbiol. 2009;20(4): 107-111. Slimings C, and TV Riley. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(4):881-91. Spellberg B, Srinivasan A, and HF Chambers. New Societal Approaches to Empowering Antibiotic Stewardship. JAMA. 2016;315(12):1229-30. Stevens V, Dumyati G, Fine LS, Fisher SG, and E van Wijngaarden Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis. 2011;53(1):42-8. Thampi N, Showler A, Burry L, Bai AD, Steinberg M, Ricciuto DR, et al. Multicenter study of health care cost of patients admitted to hospital with Staphylococcus aureus bacteremia: Impact of length of stay and intensity of care. Am J Infect Control. 2015;43(7):739-44. Theodoros KT, and H Romney. Daptomycin Nonsusceptible Enterocci: An Emerging Challenge for Clinicians. Clin Infect Dis. 2011; 52(2): 228-234. Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, amd GL Daikos. Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect. 2014;20(9):862-72. Valiquette L, Cossette B, Garant MP, Diab H, and J Pepin. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45 Suppl 2:S112-21. Van den Bosch CM, Geerlings, SE, Natsch S et al. Quality indicators to measure appropriate antibiotic use in hospitalized adults. Clin Infect Dis. 2015;60:281-91. VGH Twele, Moyen LE, Zhang K., Dalton B, Church D, and J Conly. Methicillin-Resistant Staphylococcus aureus Endocarditis and de Novo Development of Daptomycin Resistance during Therapy. Can J Infect Dis Med Microbiol. 2010;21(2), 89-93. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323-9. Xie GH, Fang XM, Fang Q, Wu XM, Jin YH, Wang JL, et al. Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients. Crit Care. 2008;12(1):R5. Zed PJ, Abu-Laban RB, Balen RM et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ. 2008;178(12):1563-1569. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-46. 1REFERENCES Canada A. Required Organizational Practices Handbook 2017. Ottawa, Canada: Accreditation Canada; 2016. 2 Schuts EC, Hulscher ME, Mouton JW, Verduin CM, Stuart JW, Overdiek HW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847-56. 3 Valiquette L, Cossette B, Garant MP, Diab H, and J Pepin. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45 Suppl 2:S112-21. 4 Public Health Agency of Canada. Canadian Antimicrobial Resistance Surveillance System--Report 2016. Ottawa, Canada; 2016. 5Mitchell BG, and A Gardner. Mortality and Clostridium difficile infection: a review. Antimicrobial resistance and infection control. 2012;1(1):20. 6 Miller MA, Hyland M, Ofner-Agostini M, Gourdeau M, and M Ishak. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol. 2002;23(3):137-40. 7 Bai AD, Showler A, Burry L, Steinberg M, Ricciuto DR, Fernandes T, et al. Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study. Clin Infect Dis. 2015;60(10):1451-61. 8 Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, and GL Daikos. Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect. 2014;20(9):862-72. 9 Leal JR, Heitman SJ, Conly JM, Henderson EA, and BJ Manns. Cost-Effectiveness Analysis of the Use of Probiotics for the Prevention of Clostridium difficile-Associated Diarrhea in a Provincial Healthcare System. Infect Control Hosp Epidemiol. 2016;37(9):1079-86. 10 Thampi N, Showler A, Burry L, Bai AD, Steinberg M, Ricciuto DR, et al. Multicenter study of health care cost of patients admitted to hospital with Staphylococcus aureus bacteremia: Impact of length of stay and intensity of care. Am J Infect Control. 2015;43(7):739-44. 11 Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323-9. 12 CDC. Core elements of hospital antibiotic stewardship programs. In: Services UDoHaH, editor. Atlanta, GA: The National Center for Emerging and Zoonotic Infectious Diseases; 2014. 13 Le Coz, P, Carlet, J, Roblot F, and C Pulcini. Ressources humaines nécessaires aux équipes multidisciplinaires en antibiothérapie dans les établissements de santé français. Medecine et Maladies Infectieuses 2016; 46(4): 200-206. 14 Haley RW, Morgan WM, Culver DH, White JW, Emori TG, Mosser J, et al. Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment. Am J Infect Control. 1985;13(3):97-108. 15 O'Boyle C, Jackson M, and SJ Henly. Staffing requirements for infection control programs in US health care facilities: Delphi project. Am J Infect Control. 2002;30(6):321-33. 16 Santé et Services sociaux Québec. Comité d'examen sur la prévention et le contrôle des infections nosocomiales. D'abord ne pas nuire... les infections nosocomiales au Québec, un problème majeur de santé, une priorité. Québec City, QC2002. 17 Spellberg B, Srinivasan A, and HF Chambers. New Societal Approaches to Empowering Antibiotic Stewardship. JAMA. 2016;315(12):1229-30. 18 Armstrong, GL., LA Conn and RW Pinner. Trends in infectious disease mortality in the United States during the 20th century. JAMA. 1999;281(1): 61-66. 19 Novotny J, and M Novotny. Adverse drug reactions to antibiotics and major antibiotic drug interactions. Gen. Physiol. Biophys. 1999;18:126–139. 20 Zed PJ, Abu-Laban RB, Balen RM et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ. 2008;178(12):1563-1569. 21 Hecker MT, Aron DC, Patel NP, Lehmann MK and CJ Donskey. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003;163(8): 972-978. 22 Dellit, TH et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2): 159-177. 23 Hooton TM, et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med. 2000;343(14): 992-997. 24 Lin, L, K Fajardo and U. S. P. S. T. Force. Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008;149(1): W20-24. 25 Silver SA, Baillie L and AE Simor. Positive urine cultures: A major cause of inappropriate antimicrobial use in hospitals? Can J Infect Dis Med Microbiol. 2009;20(4): 107-111. 26 Rice, LB. The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile. Clin Infect Dis. 2008;6(4): 491-496. 27 Sandberg, T et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet 2012; 380(9840): 484-490. 28 Sawyer, RG et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 2015; 372(21): 1996-2005. 29 Chastre, J, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290(19): 2588-2598. 30 Rafailidis, PI, AI Pitsounis and ME Falagas. Meta-analyses on the optimization of the duration of antimicrobial treatment for various infections. Infect Dis Clin North Am. 2009;23(2): 269-276. 31 Kim JH, and HA Gallis. Observations on Spiraling Empiricism: Its Causes, Allure, and Perils with Particular Reference to Antibiotic Therapy. Am J Med. 1989;87:201-206. 32 Charani E, Castro-Sanchez E, Sevdalis N et al. Understanding the determinants of antimicrobial prescribing within hospitals: The role of prescribing etiquette. Clinical Infectious Diseases 2013;57(2):188–96. 33 Rahal, JJ, et al. Class Restriction of Cephalosporin Use to Control Total Cephalosporin Resistance in Nosocomial Klebsiella. JAMA. 1998;280(14): 1233-123. 34 Burke, JP. Antibiotic Resistance—Squeezing the Balloon? JAMA. 1998;280(14): 1270-1271. 35 Meyer, E, Gastmeier E, Deja M and F Schwab. Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol. 2013;303(6-7): 388-395. 36 MacDougall, CJ, Powell P, Johnson CL, Edmond MB and RE Polk. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis. 2005;41(4): 435-440. 37 Fleming A, Chain E, et al. Penicillin and streptomycin. Lancet. 1947;2(6472):397. 38 McGowan JE, Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis. 1983;5(6):1033-48. 39 Årdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, Directory: Content Content -> Resolution Content -> American bar association adopted by the house of delegates Content -> Additional File 26 Content -> Guide to completing the collection using the Omnibus system Content -> Management and Marketing Content -> Sigaccess annual Report Content -> Study Guide For Students Only Dress Rehearsal January 29, 2014 7: 00 pm jubilee Auditorium Content -> Benjamin Franklin: In Search of a Better World Section One Content -> Extended range forecast of atlantic seasonal hurricane activity and landfall strike probability for 2013 Download 143.1 Kb. Share with your friends:
|